Transforming Patient Care on the Move...
-Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced the successful first surgery using its new, advanced Activit-E™ polyethylene for the Truliant® knee replacement system....
Gamma Tech will distribute Pearl’s flagship AI solution, Second Opinion®, to the ANZ dental markets...
Chula medical researchers have developed lightweight and easy-to-use Parkinson's gloves that can automatically reduce tremors, allowing Parkinson's Disease patients to enjoy social life and reducing side effects from medication and risk from brain surgery....
Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced the phase-one completion of the company’s first anonymized global dialysis dataset—coined the Apollo database project—the foundation of the company’s long-term AI aspirations. Intended to advance patient care quality and outcomes by making kidney disease care more personalized and precise, the database provides a highly sophisticated view into the clinical care provided ...
Measuring urine volume based on the difference in body weight before and after urination, eliminating the need for urine collection...
Evoke Neuroscience, a leading force in cognitive health, is proud to unveil its latest innovation, the Evoke EEG System with the world's largest human brain EEG and ERP database. ...
GE HealthCare a collaboration with Novo Nordisk to further advance the clinical and product development of peripheral focused ultrasound (PFUS). This is a novel technology that has potential to specifically regulate metabolic function in the body using ultrasound that may support the treatment of chronic diseases such as type 2 diabetes and obesity....
Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States...
Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer.1 The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer...
